Ramelteon ameliorated 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in neuronal cells in a mitochondrial-dependent pathway

References

• Zhang ZX, Roman GC, Hong Z, et al. Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet. 2005;365(9459):595–597. .
   PubMed Web of Science ®Google Scholar
• Khoo TK, Yarnall AJ, Duncan GW, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80(3):276–281. .
   PubMed Web of Science ®Google Scholar
• Lopiano L, Modugno N, Marano P, et al. Motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study. Neurol Sci. 2016;37(11):1785–1792.
   PubMed Web of Science ®Google Scholar
• Beitz JM. Parkinson’s disease: a review. Front Biosci. 2014;6(1):65–74.
   Google Scholar
• Jakubczyk K, Dec K, Kaldunska J, et al. Reactive oxygen species - sources, functions, oxidative damage. Pol Merkur Lekarski. 2020;48:124–127.
   PubMedGoogle Scholar
• Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21:363–383.
   PubMed Web of Science ®Google Scholar
• Guo JD, Zhao X, Li Y, et al. Damage to dopaminergic neurons by oxidative stress in Parkinson’s disease (Review). Int J Mol Med. 2018;41:1817–1825.
   PubMed Web of Science ®Google Scholar
• Yadav SK, Pandey S, Singh B. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: a comparative study. J Chem Neuroanat. 2017;85:50–59.
   PubMed Web of Science ®Google Scholar
• Chen MY, Fan K, Zhao LJ, et al. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson’s disease. Bioengineered. 2021;12(1):708–719.
   PubMed Web of Science ®Google Scholar
• D’Amato RJ, Benham DF, Snyder SH. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin. J Neurochem. 1987;48(2):653–658.
   PubMed Web of Science ®Google Scholar
• Sanders LH, Timothy Greenamyre J. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med. 2013;62:111–120.
   PubMed Web of Science ®Google Scholar
• Kuriyama A, Honda M, Hayashino Y. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med. 2014;15(4):385–392.
   PubMed Web of Science ®Google Scholar
• Borja NL, Daniel KL. Ramelteon for the treatment of insomnia. Clin Ther. 2006;28(10):1540–1555.
   PubMed Web of Science ®Google Scholar
• Edmonds C, Swanoski M. A Review of Suvorexant, Doxepin, Ramelteon, and Tasimelteon for the Treatment of Insomnia in Geriatric Patients. Consult Pharm. 2017;32(3):156–160.
   Google Scholar
• Wang J, Jiang C, Zhang K, et al. Melatonin receptor activation provides cerebral protection after traumatic brain injury by mitigating oxidative stress and inflammation via the Nrf2 signaling pathway. Free Radic Biol Med. 2019;131:345–355.
   PubMed Web of Science ®Google Scholar
• Wang T, Li Z, Xia S, et al. The Protective Effects of Ramelteon Against Isoflurane-Induced Insults and Inflammatory Response in Brain Microvascular Endothelial Cells. Neurotox Res. 2021;39(3):677–686.
   PubMed Web of Science ®Google Scholar
• Li CF, Liu SM, Zheng J, et al. Angelica sinensis polysaccharide (ASP) attenuates diosbulbin-B (DB)-induced hepatotoxicity through activating the MEK/ERK pathway. Bioengineered. 2021;12(1):3516–3524.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhou K, Ma L, et al. MicroRNA-145 overexpression inhibits neuroblastoma tumorigenesis in vitro and in vivo. Bioengineered. 2020;11(1):219–228.
   PubMed Web of Science ®Google Scholar
• BJ R, Hoek S, Fon EA, et al. Mitochondrial dysfunction and mitophagy in Parkinson’s: from familial to sporadic disease. Trends Biochem Sci. 2015;40(4):200–210.
   PubMed Web of Science ®Google Scholar
• Andalib S, Vafaee MS, Gjedde A. Parkinson’s disease and mitochondrial gene variations: a review. J Neurol Sci. 2014;346(1–2):11–19.
   PubMed Web of Science ®Google Scholar
• Song Q, Geng Y, Li Y, et al. Long noncoding RNA NORAD regulates MPP+-induced Parkinson’s disease model cells. J Chem Neuroanat. 2019;101:101668.
   PubMed Web of Science ®Google Scholar
• Zeng R, Luo DX, Li HP, et al. MicroRNA-135b alleviates MPP(+)-mediated Parkinson’s disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis. J Clin Neurosci. 2019;65:125–133.
   PubMed Web of Science ®Google Scholar
• Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417(1):1–13.
   PubMed Web of Science ®Google Scholar
• Starkov AA. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci. 2008;1147(1):37–52.
   PubMedGoogle Scholar
• Thallas-Bonke V, Jha JC, Gray SP, et al. Nox-4 deletion reduces oxidative stress and injury by PKC-alpha-associated mechanisms in diabetic nephropathy. Physiological reports 2014; 2.
   Google Scholar
• Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Prog Neurobiol. 2013;106-107:17–32.
   PubMed Web of Science ®Google Scholar
• Chaudhari AA, Seol JW, Kang SJ, et al. Mitochondrial transmembrane potential and reactive oxygen species generation regulate the enhanced effect of CCCP on TRAIL-induced SNU-638 cell apoptosis. J Vet Med Sci. 2008;70(6):537–542.
   PubMed Web of Science ®Google Scholar
• Lopez J, Tait SW. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer. 2015;112(6):957–962.
   PubMed Web of Science ®Google Scholar
• Martinou JC, Youle RJ. Mitochondria in apoptosis: bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011;21(1):92–101.
   PubMed Web of Science ®Google Scholar
• Ola MS, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 2011;351(1–2):41–58.
   PubMed Web of Science ®Google Scholar
• Glushakova OY, Glushakov AA, Wijesinghe DS, et al. Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: implications for chronic neurodegeneration. Brain Circ. 2017;3:87–108.
   PubMedGoogle Scholar
• Kashihara K, Nomura T, Maeda T, et al. Beneficial effects of ramelteon on rapid eye movement sleep behavior disorder associated with Parkinson’s disease-results of a multicenter open trial. Intern Med. 2016;55(3):231–236.
   PubMed Web of Science ®Google Scholar
• Wu XL, Lu SS, Liu MR, et al. Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury. Acta Pharmacol Sin. 2020;41(8):1016–1024.
   PubMed Web of Science ®Google Scholar
• Gu C, Wang F, Zhang YT, et al. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(6):e13375.
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Kaur C, Pandi-Perumal S, et al. Melatonin and its agonist ramelteon in Alzheimer’s disease: possible therapeutic value. Int J Alzheimers Dis. 2010;2011:741974.
   PubMedGoogle Scholar
• Satyanarayanan SK, Shih YH, Chien YC, et al. Anti-Oxidative Effects of Melatonin Receptor Agonist and Omega-3 Polyunsaturated Fatty Acids in Neuronal SH-SY5Y Cells: deciphering Synergic Effects on Anti-Depressant Mechanisms. Mol Neurobiol. 2018;55(9):7271–7284.
   PubMed Web of Science ®Google Scholar
• Imbesi M, Uz T, Manev H. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells. Neuroscience. 2008;155(4):1160–1164.
   PubMed Web of Science ®Google Scholar
• Imbesi M, Uz T, Dzitoyeva S, et al. Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells. Neurosci Lett. 2008;439(1):34–36.
   PubMed Web of Science ®Google Scholar